Inhibiting EGFR expression or activity has been shown to slow the progression of diabetic kidney injury, suggesting that directly targeting EGFR or its associated signaling pathways may be an effective strategy for preventing progressive kidney damage caused by diabetes [46]. This evidence concerns the gene EGFR and diabetes mellitus.